Identification of characteristics predictive of long-term survival with durvalumab or durvalumab plus tremelimumab in metastatic urothelial carcinoma

por Alt, Marie, Stecca, Carlos, Lin, Yian, Kazeem, Gbenga, Goluboff, Erik T., Sridhar, Srikala S.
Publicado 2023